Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

8

Revenue 2017

AbbVie

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AbbVie's 2013 sales performance.

AbbVie

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML

AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML AbbVie and Roche have announced the publication of results from the phase 3 VIALE-A trial of Venclyxto in patients with acute myeloid leukaemia (AML) in the New England Journal of ... 2020. AbbVie sells the drug on its own outside the US, while Roche’s

AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies

AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies AbbVie has decided to exit its existing partnership with Voyager Therapeutics for the development of gene therapies for Alzheimer’s and Parkinson’s disease. ... As part of this first deal, Voyager received $69m upfront to advance gene therapy

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

AbbVie, Amgen and Takeda team up for joint COVID-19 trial Collaborative trial will evaluate three anti-inflammatory drugs. AbbVie, Amgen and Takeda have joined forces for a clinical trial which will evaluate each company’s respective anti-inflammatory drugs in ... Unfortunately, not all efforts to repurpose

Gilead makes a play for novel cancer drug with Tizona deal

Gilead makes a play for novel cancer drug with Tizona deal Tizona is also set to spin-off development of its anti-CD39 antibody TTX-030 partnered with AbbVie. ... AbbVie paid $105m upfront as well as an undisclosed equity payment to Tizona to secure exclusive rights to the drug last year.

CLEAR HORIZONS: A New Era of Psoriasis Care

by Lucid Group for AbbVie. Despite recent advances in the understanding of psoriasis and rapid expansion in treatment options available, most patients with moderate-to-severe psoriasis still receive delayed, inadequate ... CLEAR HORIZONS: A New Era of

[ Previous 5 results ] 11 12 13 14 15 16 17 18 19 20 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...